Loading...
Loading...
Among the 5 tracked institutional investors we monitor, MREO (MEREO BIOPHARMA GROUP PLC) is held with a combined value of $1.48M across 4,498,673 shares. The largest holder is MILLENNIUM MANAGEMENT LLC with a position worth $1.17M (0.00% of their portfolio). 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$1.48M
Total Shares Held
4,498,673
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | $1.17M | 0.00% | +4155.0% |
| 2 | CITADEL ADVISORS LLC | $150.08K | 0.00% | -39.3% |
| 3 | BlackRock, Inc. | $99.99K | 0.00% | -3.1% |
| 4 | STATE STREET CORP | $44.02K | 0.00% | +2.1% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $15.97K | 0.00% | -75.1% |
As of the latest SEC 13F filings, MILLENNIUM MANAGEMENT LLC is the largest institutional holder of MREO with a position worth $1.17M, representing 0.00% of their portfolio. In total, 5 institutional investors hold MREO with a combined value of $1.48M.
Institutional investors hold $1.48M worth of MREO stock across 5 positions. The largest institutional holder is MILLENNIUM MANAGEMENT LLC with $1.17M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MREO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MREO positions.